Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
This brief explains the asset selection logic behind equal weighted indices and how different asset classes impact portfolio balance.
23,793 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
U.S. airline stocks rise on easing fuel costs, led by American Airlines and United, as crude prices slip and margins ...
Costco has quietly stacked cash, raising questions about shareholder returns. This guide explains the potential for a...
As affordability remains stressed and sales slow, seasoned real estate agents guide buyers and sellers through one of...
Tech weakness and memory-chip swings are weighing on major indexes this June. Learn what’s driving the move and how t...
Memory shortages are expanding beyond PCs to consoles and smart devices. Even Apple’s famed supply chain isn’t immune...
The supreme court rules against Trump's bid to fire Lisa Cook at the Federal Reserve, keeping her in place as the cas...
Pagaya Technologies just saw a notable insider move when its CEO purchased shares. This article examines what that co...
Tech’s latest earnings show Big Tech leaning into AI infrastructure, pushing capital spending higher as data centers ...
CoreWeave unleashed resilient US-scale growth with a massive backlog, while Nebius posted stronger margins on a small...
The Labor Department will unveil the latest jobs data on Thursday, offering a fresh read on June hiring, unemployment...
Meta Platforms shares slid in early trading as investors weighed analyst comments and evolving ad trends. This articl...